Publication | Open Access
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting
76
Citations
17
References
2023
Year
In this open-label trial, treatment of refractory viral infections/disease in allo-HCT recipients with posoleucel was feasible, safe, and effective.
| Year | Citations | |
|---|---|---|
2009 | 771 | |
2011 | 689 | |
2007 | 637 | |
2006 | 543 | |
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation Ifigeneia Tzannou, Swati Naik, Kathryn Leung, Bk VirusCell TherapyTransplantationEpstein-barr VirusStem Cell Transplantation | 2017 | 439 |
2014 | 391 | |
2002 | 363 | |
1993 | 175 | |
2017 | 169 | |
2007 | 129 |
Page 1
Page 1